To confirm PPARα activation with CF treatment, hepatic mRNA levels of PPARα and its target genes were measured in mothers at pregnancy day 18 (Fig 2A) and offspring at E18, P7 and P84 (Fig 2B). This evidence concerns the gene PPARA and cystic fibrosis.